Results 101 to 110 of about 355,526 (241)
Cancer in Systemic Sclerosis: Clinical Associations and Prognostic Impact From the EUSTAR Registry
Objective Cancer represents a major cause of death in systemic sclerosis (SSc). Established risk factors are limited to specific subsets, particularly early diffuse anti‐RNA polymerase III (POLR3)–positive disease, needing further exploration. Methods We performed a nested case‐control study within the European Scleroderma Trials and Research group ...
Antonio Tonutti +52 more
wiley +1 more source
New therapeutic options for metabolic‐associated steatotic liver disease
An increasing number of patients are being diagnosed with metabolic dysfunction‐associated steatotic liver disease (MASLD). MASLD results from disturbances in hepatic lipid metabolism and is associated with an increased risk of cirrhosis and hepatocellular carcinoma and significant extrahepatic morbidity, including cardiovascular disease and ...
Tessa Straatmijer, Midas Mulder
wiley +1 more source
In this paper, the reverse-link performance of synchronous DS-CDMA cellular networks is investigated in Rician multipath fading environments. The system’s performance is evaluated in terms of the achievable average bit error rate (BER) and the user ...
Hwang, S-H., Hanzo, L.
core +1 more source
Objective: We present a case of synchronous malignancies of rare bladder small cell neuroendocrine carcinoma (SCNC) and prostate adenocarcinoma and provide literature review of bladder SCNC. Case(s) presentation: A 72-year-old male smoker presented with
Clarissa Tania +4 more
doaj +1 more source
Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu +5 more
wiley +1 more source
Multiple primary malignant tumors (MPMT), particularly when presenting synchronously—defined as two or more distinct primary malignancies diagnosed within 6 months—are rare and present considerable diagnostic and therapeutic challenges.
Udip Maheshwari +4 more
doaj +1 more source
Programmable three‐state nanoreactor for spatiotemporally controlled tumor therapy
The OMVs are shielded with a biocompatible Da–Ca shell, which prolongs its circulation period and promotes intratumoral accumulation. Importantly, the biocompatible Da–Ca shell can be controllably disintegrated in tumor microenvironment by using laser irradiation, generating in situ hyperthermia and releasing Ca2+.
Guihong Lu +12 more
wiley +1 more source
Concomitant Malignancies of the Gall Bladder and Pancreas: A Synchronous Oncologic Challenge
Synchronous malignancies involving the pancreas and gallbladder are exceedingly rare and often diagnosed incidentally during surgical exploration. We report a case of a 60-year-old male who presented with obstructive jaundice, pruritus, and epigastric ...
Anuradha Dnyanmote, Vedanth Tirmanwar
doaj +1 more source
Tackling cancer stemness with nanotechnology in the era of precision medicine
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo +9 more
wiley +1 more source
Renal cell carcinoma (RCC) and multiple myeloma (MM) represent distinct malignancies with disparate origins and clinical presentations, yet emerging evidence suggests a potential association between them, evidenced by a higher-than-expected co-occurrence
Pallavi Dubey +5 more
doaj +1 more source

